| Product NDC: | 49884-459 |
| Proprietary Name: | Fentanyl Citrate |
| Non Proprietary Name: | Fentanyl Citrate |
| Active Ingredient(s): | 200 ug/1 & nbsp; Fentanyl Citrate |
| Administration Route(s): | ORAL; TRANSMUCOSAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-459 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077312 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111017 |
| Package NDC: | 49884-459-55 |
| Package Description: | 30 BLISTER PACK in 1 CARTON (49884-459-55) > 1 LOZENGE in 1 BLISTER PACK (49884-459-52) |
| NDC Code | 49884-459-55 |
| Proprietary Name | Fentanyl Citrate |
| Package Description | 30 BLISTER PACK in 1 CARTON (49884-459-55) > 1 LOZENGE in 1 BLISTER PACK (49884-459-52) |
| Product NDC | 49884-459 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fentanyl Citrate |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL; TRANSMUCOSAL |
| Start Marketing Date | 20111017 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 200 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |